Sunday, July 12, 2009 5:06:07 PM
Link is to an article by Chris O'Brien in Sunday's 7/12/09 San Jose Mercury News "Fate of my Forecasts." Look at #8: to whit biotech mergers and acquisitions have been quiet in first half of 2009. Perhaps this is why Takeda was able to steal IDM for $2.64 a share.
I am convinced that if IDM had been sold about 18 months ago (I know I am dreaming) it would have sold for between $7 to $12 a share, about +250% to 350%. But it did not happen.
http://www.mercurynews.com/ci_12804210?nclick_check=1
Cheers to all and GLTU. Bow
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM